Clinical Trial Update: Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature [Phase 3]

View source ↗

Summary

Phase 3 outpatient trial results evaluating the safety and effectiveness of the Low Glucose Suspend feature in an insulin pump for Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Medtronic MiniMed Insulin Pump with Low Glucose Suspend

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-03-17